Clinical Trial: Subcutaneous Immunoglobulin for CIDP

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional




Official Title: A Study of Subcutaneous Immunoglobulin as Chronic Treatment for Patients With Chronic Inflammatory Demyelinating Polyneuropathy

Brief Summary: The investigators are using self administered subcutaneous IG in patients with CIDP who require IVIG. Safety, efficacy, and patient satisfaction will be examined.